Axsome Therapeutics Inc
AXSMHealthcare·Biotechnology·USA·Mid·NASD·Nov 12 • 3:59 PM ET
144.37-4.87 (-3.26%)
2026-11-13 13:29 CET
Market cap
$7.59B
Revenue, TTM
865.27 USD m
Net income, TTM
-157.29 USD m
Free cash flow, TTM
-82.61 USD m
EPS diluted, TTM
-3.06
Price
AXSM against its 20, 50 and 200-day averagesPatternshover a marker to name it
44.5% under the 52-week high of 260.19 on 18 Jun 2026. 52-week low 123.00 on 2 Nov 2026. Last 15 sessions, 25.8% high to low
Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average
Setup. RS line 24
CANSLIM 4 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 2 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Average True Range: Under 2
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 2 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
AXSM52-week range, 16% of the way up
123.00260.19
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
| Index | RUI |
|---|---|
| Employees | 925 |
| IPO | Nov 19, 2015 |
| Beta | 0.84 |
| ATR, 14d | 7.74 |
| Rel volume | 0.00 |
| Short float | 7.35% |
| Insider own | 15.65% |
| Inst own | 74.21% |
Snapshot
6 groupsValuation
| Index | RUI |
|---|---|
| Market Cap | $7.59B |
| Enterprise Value | 7.50B |
| Income | -157.29M |
| Sales | 865.27M |
| Book / share | 2.01 |
| Cash / share | 5.97 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 925 |
| IPO | Nov 19, 2015 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | 41.03 |
| Price / earnings / growth | - |
| Price / sales | 8.78 |
| Price / book | 71.99 |
| Price / cash | 24.20 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 8.67 |
| Quick Ratio | 1.34 |
| Current Ratio | 1.42 |
| Debt / equity | 2.13 |
| Long-term debt / equity | 1.40 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -3.06 |
|---|---|
| Earnings next year | 3.52 |
| Earnings next quarter | -0.05 |
| Earnings this year | 30.52% |
| Earnings next year | 237.61% |
| Earnings growth, 5 years | - |
| Past earnings growth | 7.17% -5.89% |
| Past sales growth | 133.68% - |
| Earnings vs last year | 34.51% |
| Sales vs last year | 54.16% |
| Earnings vs last quarter | 74.00% |
| Sales vs last quarter | 51.87% |
| Earnings | Nov 02 BMO |
| Surprise | 60.59% 4.21% |
Ownership
| Insiders own | 15.65% |
|---|---|
| Insider trades | -2.50% |
| Institutions own | 74.21% |
| Institution trades | 0.92% |
| Return on assets | -21.03% |
| Return on equity | -175.59% |
| Return on capital | -62.06% |
| Gross Margin | 92.02% |
| Operating margin | -18.88% |
| Profit Margin | -18.18% |
| 20-day average | -0.12% |
| 50-day average | -16.44% |
| 200-day average | -26.81% |
Technical
| Shares out | 52.58M |
|---|---|
| Shares floating | 44.37M |
| Short / float | 7.35% |
| Short ratio | 3.87 |
| Short interest | 3.26M |
| 52-week high | 260.19 -44.5% |
| 52-week low | 123.00 +17.4% |
| Volatility | 4.73% 5.10% |
| Average range | 7.74 |
| Strength index | 42.88 |
| Market sensitivity | 0.84 |
| Relative volume | 0.00 |
| Avg Volume | 843.43K |
| Volume | 0 |
Performance
| Perf Week | 11.22% |
|---|---|
| Perf Month | -11.00% |
| Perf Quarter | -32.43% |
| Perf Half Y | -37.84% |
| Perf YTD | -20.95% |
| Perf Year | 2.49% |
| Perf 3Y | 151.43% |
| Perf 5Y | 267.73% |
| Perf 10Y | 1877.67% |
| Recommendation | 1.13 |
| Target Price | 264.62 |
| Prev Close | 144.37 |
| Price | 144.37 |
| Change % | 0.00% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 23, 2026 | Resumed | Truist | Buy | $285 | +97.4% |
| Jul 21, 2026 | Initiated | BMO Capital Markets | Outperform | $310 | +114.7% |
| Feb 24, 2026 | Initiated | Wolfe Research | Outperform | $230 | +59.3% |
| Jan 08, 2026 | Downgrade | Morgan Stanley | Overweight → Equal-Weight | $204 | +41.3% |
| Oct 01, 2025 | Initiated | B. Riley Securities | Buy | $179 | +24.0% |
| Sep 03, 2025 | Resumed | Wells Fargo | Overweight | $163 | +12.9% |
| Jul 03, 2025 | Resumed | Morgan Stanley | Overweight | $190 | +31.6% |
| Jun 03, 2025 | Initiated | Oppenheimer | Outperform | $185 | +28.1% |
| Apr 07, 2025 | Initiated | Jefferies | Buy | $200 | +38.5% |
| Feb 11, 2025 | Initiated | Deutsche Bank | Buy | $176 | +21.9% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | 15.41B |
| HRMY | Harmony Biosciences Holdings Inc | 2.01B |
| ACAD | Acadia Pharmaceuticals Inc | 3.13B |
| NBIX | Neurocrine Biosciences Inc | 17.31B |
| ALKS | Alkermes plc | 7.89B |
| PRAX | Praxis Precision Medicines Inc | 9.08B |
| SUPN | Supernus Inc | 6.07B |
| BHVN | Biohaven Ltd | 2.12B |
| XENE | Xenon Pharmaceuticals Inc | 4.08B |
| TEVA | Teva- Pharmaceutical Industries Ltd | 51.11B |
Insider trading
latest 14 of 81| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Jacobson Mark L. | Chief Operating Officer | Sep 03 '26 | Option Exercise | 12.95 | 10,000 | 129,500 | 10,000 | Sep 03 07:09 PM |
| Jacobson Mark L. | Chief Operating Officer | Sep 03 '26 | Sale | 208.65 | 10,000 | 2,086,500 | 0 | Sep 03 07:09 PM |
| Mark Jacobson | Officer | Sep 03 '26 | Proposed Sale | 208.35 | 10,000 | 2,083,500 | Sep 03 05:43 PM | |
| TABUTEAU HERRIOT | Chief Executive Officer | Aug 05 '26 | Option Exercise | 4.95 | 45,004 | 222,770 | 52,233 | Aug 07 07:00 PM |
| TABUTEAU HERRIOT | Chief Executive Officer | Aug 06 '26 | Option Exercise | 4.95 | 4,660 | 23,067 | 11,889 | Aug 07 07:00 PM |
| TABUTEAU HERRIOT | Chief Executive Officer | Aug 05 '26 | Sale | 212.01 | 45,004 | 9,541,298 | 7,229 | Aug 07 07:00 PM |
| TABUTEAU HERRIOT | Chief Executive Officer | Aug 06 '26 | Sale | 213.95 | 4,660 | 997,007 | 7,229 | Aug 07 07:00 PM |
| Herriot Tabuteau | Officer | Aug 06 '26 | Proposed Sale | 210.13 | 4,660 | 979,206 | Aug 06 05:09 PM | |
| Herriot Tabuteau | Officer | Aug 05 '26 | Proposed Sale | 212.85 | 45,004 | 9,579,101 | Aug 05 06:04 PM | |
| TABUTEAU HERRIOT | Chief Executive Officer | Jul 01 '26 | Option Exercise | 4.95 | 49,666 | 245,847 | 56,895 | Jul 01 07:30 PM |
| TABUTEAU HERRIOT | Chief Executive Officer | Jul 01 '26 | Sale | 240.25 | 49,666 | 11,932,256 | 7,229 | Jul 01 07:30 PM |
| Herriot Tabuteau | Officer | Jul 01 '26 | Proposed Sale | 240.66 | 49,666 | 11,952,620 | Jul 01 05:35 PM | |
| JEFFS ROGER | Director | Jun 11 '26 | Sale | 249.12 | 286 | 71,248 | 58,367 | Jun 11 08:34 PM |
| JEFFS ROGER | Director | Jun 10 '26 | Sale | 246.18 | 286 | 70,407 | 58,653 | Jun 11 08:34 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | AUM: 3.07B |
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
| IWP | iShares Russell Mid-Cap Growth ETF | AUM: 18.49B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| IWR | iShares Russell Mid-Cap ETF | AUM: 59.29B |
| IWF | iShares Russell 1000 Growth ETF | AUM: 119.30B |
News
latest 14 of 200- AXSM Stock Has Slumped Nearly 20% Over The Past Month, But BofA Sees Selloff As Overdone (Stocktwits)
- Axsome Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
- AXSM Stock Hits Fresh 52-Week Lows As Launch Concerns Of Auvelity In Alzheimer's Care Outweigh Q3 Beat (Stocktwits) -5.83%
- Axsome Beats Handily As Auvelity Growth Accelerates, But A Battered Stock Shows Investors Still Doubt The Ramp (Earnings Whispers)
- Axsome Therapeutics Shares Rise 2.13% as Q3 Revenue Jumps 52% and Loss Narrows (InvestorsHub)
- Axsome: Q3 Earnings Snapshot (Associated Press)
- Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
- Axsome's Alzheimer's Agitation Launch Faces First Full-Quarter Test As Shares Slide Toward Lows (Earnings Whispers)
- Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2 (GlobeNewswire)
- Jefferies Highlights Three Biotech Stocks With Blockbuster Potential (Investing.com)
- Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer's Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer's Day (GlobeNewswire)
- Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026 (GlobeNewswire)
- AXSM Jumps 6% As Mizuho Calls Auvelitys Alzheimers Launch A Strong Start (Stocktwits)
- Axsome Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Quarterly earnings
2026Q3 EPS -0.250 beat -0.634, from -0.940 a year earlier. Sales 259.69 beat 249.19, from 170.99 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-02 08:30 | -0.250 | -0.634 | -0.250 | 259.69 | 249.19 | EPS -60.6% · sales +4.2% | vs 2025Q3, year-ago quarter · EPS -73.4% · sales +51.9% | 22 EPS · 20 sales | Open -5.04% vs SPY +0.49%. Close -5.83% vs SPY -0.48% |
| 2026Q2ended 2026-06-30 | 2026-08-10 08:30 | -0.990 | -0.892 | -0.991 | 216.36 | 221.11 | EPS +11.0% · sales -2.2% | vs 2025Q2, year-ago quarter · EPS +2.1% · sales +44.2% | 20 EPS · 19 sales | Open +1.48% vs SPY -0.09%. Close +3.83% vs SPY -0.03% |
| 2026Q1ended 2026-03-31 | 2026-05-04 08:30 | -1.260 | -0.844 | -1.261 | 189.4 | 190.91 | EPS +49.2% · sales -0.8% | vs 2025Q1, year-ago quarter · EPS +3.3% · sales +55.9% | 20 EPS · 19 sales | Open +2.65% vs SPY -0.08%. Close +8.31% vs SPY -0.37% |
| 2025Q4ended 2025-12-31 | 2026-02-23 08:30 | -0.560 | -0.694 | -0.564 | 194.7 | 193.36 | EPS -19.3% · sales +0.7% | vs 2024Q4, year-ago quarter · EPS -63.6% · sales +63.9% | 19 | Open -3.97% vs SPY -0.23%. Close -4.88% vs SPY -1.02% |
| 2025Q3ended 2025-09-30 | 2025-11-03 08:30 | -0.940 | -0.861 | -0.944 | 170.99 | 162.67 | EPS +9.2% · sales +5.1% | vs 2024Q3, year-ago quarter · EPS -29.9% · sales +64.8% | 20 EPS · 19 sales | Open -8.22% vs SPY +0.53%. Close +0.56% vs SPY +0.19% |
| 2025Q2ended 2025-06-30 | 2025-08-04 08:30 | -0.970 | -1.055 | -0.970 | 150.04 | 138.02 | EPS -8.1% · sales +8.7% | vs 2024Q2, year-ago quarter · EPS -41.9% · sales +72.1% | 19 EPS · 18 sales | Open +4.83% vs SPY +0.64%. Close +3.42% vs SPY +1.52% |
| 2025Q1ended 2025-03-31 | 2025-05-05 08:30 | -1.220 | -1.351 | -1.216 | 121.46 | 119.16 | EPS -9.7% · sales +1.9% | vs 2024Q1, year-ago quarter · EPS -15.3% · sales +62.0% | 17 | Open +1.67% vs SPY -0.74%. Close +3.81% vs SPY -0.57% |
| 2024Q4ended 2024-12-31 | 2025-02-18 08:30 | -1.540 | -1.001 | -1.543 | 118.77 | 118.07 | EPS +53.8% · sales +0.6% | vs 2023Q4, year-ago quarter · EPS -26.0% · sales +66.0% | 17 EPS · 16 sales | Open -4.95% vs SPY +0.19%. Close -2.33% vs SPY +0.29% |
| 2024Q3ended 2024-09-30 | 2024-11-12 08:30 | -1.340 | -1.384 | -1.342 | 103.74 | 98.37 | EPS -3.1% · sales +5.5% | vs 2023Q3, year-ago quarter · EPS +1.5% · sales +79.5% | 17 EPS · 16 sales | Open +4.42% vs SPY -0.01%. Close +9.35% vs SPY -0.31% |
| 2024Q2ended 2024-06-30 | 2024-08-05 08:30 | -1.670 | -1.307 | -1.668 | 87.17 | 86.92 | EPS +27.8% · sales +0.3% | vs 2023Q2, year-ago quarter · EPS +8.4% · sales +86.7% | 17 EPS · 16 sales | Open -13.23% vs SPY -3.99%. Close -1.43% vs SPY -2.91% |
| 2024Q1ended 2024-03-31 | 2024-05-06 08:30 | -1.440 | -1.205 | -1.442 | 75.00 | 73.29 | EPS +19.6% · sales +2.3% | vs 2023Q1, year-ago quarter · EPS +453.8% · sales -20.7% | 15 EPS · 14 sales | Open +0.27% vs SPY +0.48%. Close +1.52% vs SPY +1.03% |
| 2023Q4ended 2023-12-31 | 2024-02-20 08:30 | -2.080 | -1.171 | -2.084 | 71.53 | 69.24 | EPS +77.6% · sales +3.3% | vs 2022Q4, year-ago quarter · EPS +47.5% · sales +193.2% | 14 EPS · 13 sales | Open -8.42% vs SPY -0.36%. Close -12.57% vs SPY -0.55% |
| 2023Q3ended 2023-09-30 | 2023-11-06 08:30 | -1.320 | -1.203 | -1.320 | 57.79 | 54.87 | EPS +9.7% · sales +5.3% | vs 2022Q3, year-ago quarter · EPS +23.4% · sales +243.1% | 11 EPS · 10 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-07 08:30 | -1.540 | -1.213 | -1.538 | 46.70 | 40.88 | EPS +26.9% · sales +14.2% | vs 2022Q2, year-ago quarter · EPS +45.3% · sales +429.5% | 11 EPS · 10 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-08 08:30 | -0.260 | -1.304 | -0.258 | 94.58 | 25.47 | EPS -80.1% · sales +271.3% | vs 2022Q1, year-ago quarter · EPS -74.8% · sales - | 10 EPS · 11 sales | - |
| 2022Q4ended 2022-12-31 | 2023-02-27 08:30 | -1.410 | -1.126 | -1.410 | 24.40 | 21.75 | EPS +25.2% · sales +12.2% | vs 2021Q4, year-ago quarter · EPS +56.7% · sales - | 16 EPS · 14 sales | - |
Annual earnings
2025FY EPS -3.680 beat -3.758, from -5.990 a year earlier. Sales 638.5 beat 635.67, from 385.69 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 26.608 | - | - | 3,520 | 5.43 |
| 2029FYestimate | - | 19.630 | - | - | 2,839 | 7.36 |
| 2028FYestimate | - | 10.332 | - | - | 2,057 | 13.97 |
| 2027FYestimate | - | 3.518 | - | - | 1,462 | 41.03 |
| 2026FYestimate | - | -2.557 | - | - | 954.09 | - |
| 2025FY | -3.680 | -3.758 | -3.680 | 638.5 | 635.67 | - |
| 2024FY | -5.990 | -5.456 | -5.994 | 385.69 | 385.05 | - |
| 2023FY | -5.270 | -4.264 | -5.267 | 270.6 | 268.3 | - |
| 2022FY | -4.600 | -4.333 | -4.603 | 50.00 | 46.98 | - |
| 2021FY | -3.470 | -3.508 | -3.466 | 0.00 | 0.00 | - |
| 2020FY | -2.770 | -2.741 | -2.766 | 0.00 | 0.00 | - |
| 2019FY | -2.010 | -1.771 | -2.009 | 0.00 | 0.00 | - |
| 2018FY | -1.150 | -1.125 | -1.152 | 0.00 | 0.00 | - |
| 2017FY | -1.270 | -1.285 | -1.270 | 0.00 | 0.00 | - |
| 2016FY | -1.420 | -1.457 | -1.420 | 0.00 | 0.00 | - |
| 2015FY | -0.880 | -0.970 | -1.020 | 0.00 | 0.00 | - |
Quarterly results
2026Q3 revenue 259.69, from 170.99 a year earlier. Operating margin -5.2%, from -19.3% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -2.56 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-06 | -2.56 | -2.5% |
| 2026Q4 | E | per share | 2026-11-06 | -0.05 | -40.6% |
| 2026FY | R | per share | 2026-11-06 | -2.56 | -2.5% |
| 2026Q4 | R | per share | 2026-11-06 | -0.05 | -40.6% |
| 2026FY | S | - | 2026-11-06 | 954.09 | +0.3% |
| 2026Q4 | S | - | 2026-11-06 | 284.03 | +0.6% |
| 2026Q3 | E | per share | 2026-10-28 | -0.63 | +0.4% |
| 2026Q3 | R | per share | 2026-10-28 | -0.63 | +0.4% |
| 2026Q3 | S | - | 2026-10-28 | 249.19 | 0.0% |
| 2026Q2 | E | per share | 2026-07-30 | -0.89 | +0.1% |
| 2026Q2 | R | per share | 2026-07-30 | -0.89 | +0.1% |
| 2026Q2 | S | - | 2026-07-30 | 221.11 | +0.1% |
| 2026Q1 | E | per share | 2026-05-04 | -0.81 | 0.0% |
| 2026Q1 | R | per share | 2026-05-04 | -0.86 | 0.0% |
| 2026Q1 | S | - | 2026-05-04 | 191.22 | 0.0% |
| 2025FY | E | per share | 2026-02-23 | -3.75 | -0.1% |
| 2025Q4 | E | per share | 2026-02-23 | -0.69 | -0.2% |
| 2025FY | R | per share | 2026-02-23 | -3.71 | -0.4% |
| 2025Q4 | R | per share | 2026-02-23 | -0.67 | -5.7% |
| 2025FY | S | - | 2026-02-23 | 636.77 | +0.2% |
| 2025Q4 | S | - | 2026-02-23 | 194.55 | +0.6% |
| 2025Q3 | E | per share | 2025-10-30 | -0.86 | -0.5% |
| 2025Q3 | S | - | 2025-10-30 | 162.96 | +0.2% |
| 2025Q3 | R | per share | 2025-10-19 | -0.82 | 0.0% |
| 2025Q2 | E | per share | 2025-08-04 | -1.05 | 0.0% |
| 2025Q2 | R | per share | 2025-08-04 | -1.13 | 0.0% |
| 2025Q2 | S | - | 2025-08-04 | 138.25 | 0.0% |
| 2025Q1 | E | per share | 2025-05-05 | -1.35 | 0.0% |
| 2025Q1 | R | per share | 2025-05-04 | -1.31 | 0.0% |
| 2025Q1 | S | - | 2025-05-04 | 119.16 | 0.0% |
| 2024FY | S | - | 2025-02-13 | 385.05 | 0.0% |
| 2024Q4 | S | - | 2025-02-13 | 118.07 | 0.0% |
| 2024FY | E | per share | 2025-02-11 | -5.46 | +0.0% |
| 2024Q4 | E | per share | 2025-02-11 | -1.00 | 0.0% |
| 2024FY | R | per share | 2025-02-11 | -5.50 | -0.3% |
| 2024Q4 | R | per share | 2025-02-10 | -0.99 | +4.0% |
| 2024Q3 | E | per share | 2024-10-23 | -1.38 | 0.0% |
| 2024Q3 | R | per share | 2024-10-23 | -1.34 | -0.1% |
| 2024Q3 | S | per share | 2024-10-23 | 98.37 | +0.1% |
| 2024Q2 | E | per share | 2024-07-30 | -1.31 | -0.4% |
| 2024Q2 | R | per share | 2024-07-30 | -1.22 | -0.9% |
| 2024Q2 | S | per share | 2024-07-30 | 86.92 | +0.3% |
| 2024Q1 | E | per share | 2024-05-05 | -1.20 | 0.0% |
| 2024Q1 | R | per share | 2024-05-05 | -1.17 | 0.0% |
| 2024Q1 | S | per share | 2024-05-05 | 73.29 | 0.0% |
| 2023FY | E | per share | 2024-02-14 | -4.26 | +0.2% |
| 2023FY | S | - | 2024-02-14 | 268.3 | +0.1% |
| 2023FY | R | per share | 2024-02-05 | -4.23 | +0.5% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -1.27 | -1.152 | -2.009 | -2.766 | -3.466 | -4.603 | -5.267 | -5.994 | -3.682 | -3.0608 | - |
| Sales USD millions | 0 | 0 | 0 | 0 | 0 | 50 | 271 | 386 | 638 | 865 | - |
| Shares million shares | 25 | 30 | 37 | 37 | 38 | 43 | 47 | 49 | 51 | - | 53 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -1.342 | -1.543 | -1.216 | -0.97 | -0.944 | -0.564 | -1.261 | -0.991 | -0.246 |
| Sales USD millions | 105 | 119 | 121 | 150 | 171 | 196 | 191 | 218 | 260 |
| Shares million shares | 48 | 49 | 49 | 50 | 50 | 51 | 51 | 52 | 53 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 865.27 | 638.50+65.5% | 385.69+42.5% | 270.60+440.8% | 50.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 69.01 | 56.54+37.0% | 41.26+25.4% | 32.90+205.8% | 10.76+827.6% | 1.16+1350.0% | 0.08+100.0% | 0.04-20.0% | 0.05 |
| Gross Profit | 796.26 | 581.95+69.0% | 344.43+44.9% | 237.70+505.1% | 39.28 | -1.16 | -0.08 | -0.04 | -0.05 |
| Selling, General and Administrative Excl. Other | 959.64 | 751.19+25.9% | 596.87+41.9% | 420.61+95.4% | 215.28+74.2% | 123.55+24.7% | 99.06+47.4% | 67.21+104.9% | 32.80 |
| Research and Development | 197.81 | 182.78-2.0% | 186.54+91.4% | 97.48+69.0% | 57.68-0.5% | 57.98-17.4% | 70.17+30.9% | 53.61+128.1% | 23.50 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -163.38 | -169.24 | -252.44 | -182.91 | -176.00 | -124.71 | -99.14 | -67.25 | -32.85 |
| Interest Expense | 12.92 | 15.93-26.2% | 21.58+234.6% | 6.45-12.0% | 7.33+28.6% | 5.70+121.8% | 2.57+107.3% | 1.24+9.7% | 1.13 |
| Unusual Expense | -12.35 | 7.91-71.9% | 28.12-42.5% | 48.92+1187.4% | 3.80 | 0.00-100.0% | 1.25 | 0.00 | -2.79 |
| Net Income Before Taxes | -156.65 | -183.70 | -287.13 | -238.28 | -187.13 | -130.40 | -102.95 | -68.48 | -31.18 |
| Income Taxes | 0.65 | -0.53-688.9% | 0.09-90.6% | 0.96 | 0.00 | 0.00 | -0.05 | -0.14 | -0.22 |
| Consolidated Net Income | -157.29 | -183.17 | -287.22 | -239.24 | -187.13 | -130.40 | -102.90 | -68.35 | -30.97 |
| Net Income From Continuing Operations | -157.29 | -183.17 | -287.22 | -239.24 | -187.13 | -130.40 | -102.90 | -68.35 | -30.97 |
| Net Income | -157.29 | -183.17 | -287.22 | -239.24 | -187.13 | -130.40 | -102.90 | -68.35 | -30.97 |
| EPS (Recurring) per share | -3.16 | -3.57 | -5.58 | -4.51 | -4.54 | -3.47 | -2.74 | -2.01 | -1.22 |
| EPS (Basic, Before Extraordinaries) per share | -3.06 | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.77 | -2.01 | -1.15 |
| EPS (Diluted) per share | -3.06 | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.77 | -2.01 | -1.15 |
| EBITDA | -152.80 | -160.17 | -244.48 | -176.07 | -170.44 | -123.55 | -99.06 | -67.21 | -32.80 |
| Non-Operating Income (Expense) | 7.30 | 9.37-37.6% | 15.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 83.66 | 74.06+10.0% | 67.32+36.1% | 49.47+31.1% | 37.73+81.4% | 20.80+40.9% | 14.76+141.2% | 6.12+249.7% | 1.75 |
| Price To Sales Ratio ratio | 11.18 | 14.23 | 10.51 | 13.36 | 62.67 | - | - | - | - |
| Gross Margin % | 92.02 | 91.14 | 89.30 | 87.84 | 78.49 | - | - | - | - |
| Operating Margin % | -18.88 | -26.51 | -65.45 | -67.59 | -351.74 | - | - | - | - |
| Net Margin % | -18.18 | -28.69 | -74.47 | -88.41 | -373.99 | - | - | - | - |
| Shares Outstanding million shares | 52.58 | 50.88+4.5% | 48.67+2.8% | 47.35+8.9% | 43.50+15.0% | 37.82+1.2% | 37.37+1.2% | 36.93+22.7% | 30.09 |
| Market Capitalization | 7,593.86 | 7,593.86+85.2% | 4,100.40+8.9% | 3,766.16+12.4% | 3,349.46+135.2% | 1,423.99-53.2% | 3,042.43-20.0% | 3,804.54+4425.4% | 84.07 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 259.69+51.9% | 218.38+45.5% | 191.20+57.4% | 196.00+65.0% | 170.99+63.2% | 150.04+72.1% | 121.46+61.9% | 118.77+66.0% |
| Cost of Goods Sold Incl. D&A | 20.86+45.7% | 16.45+5.7% | 17.09+43.4% | 14.60+16.0% | 14.32+36.4% | 15.57+57.1% | 11.92+46.6% | 12.59+38.0% |
| Gross Profit | 238.83+52.4% | 201.92+50.2% | 174.11+58.9% | 181.40+70.8% | 156.67+66.2% | 134.47+74.0% | 109.54+63.8% | 106.18+70.1% |
| Selling, General and Administrative Excl. Other | 252.28+33.1% | 253.07+41.2% | 236.88+43.6% | 217.42+29.6% | 189.59+34.9% | 179.28+17.1% | 165.01+21.7% | 167.81+42.8% |
| Research and Development | 50.49+26.1% | 46.08-7.0% | 52.56+18.9% | 48.68-11.3% | 40.04-10.9% | 49.54-0.1% | 44.22+20.9% | 54.88+78.9% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -13.45 | -51.14 | -62.77 | -36.02 | -32.92 | -44.82 | -55.47 | -61.63 |
| Interest Expense | 3.42+1.2% | 3.20-21.8% | 3.09-41.3% | 3.21-53.8% | 3.38-30.9% | 4.09-16.0% | 5.26+8.0% | 6.95+892.9% |
| Unusual Expense | -2.38-118.0% | -1.50-165.8% | 0.59-60.9% | -9.07-182.6% | 13.19-19.5% | 2.28+5.6% | 1.51 | 10.98-74.6% |
| Net Income Before Taxes | -12.79 | -51.19 | -64.54 | -28.13 | -47.23 | -48.93 | -59.41 | -74.83 |
| Income Taxes | 0.09 | 0.13 | 0.00 | 0.43+377.8% | 0.00 | -0.96 | 0.00 | 0.09 |
| Consolidated Net Income | -12.88 | -51.31 | -64.54 | -28.56 | -47.23 | -47.97 | -59.41 | -74.91 |
| Net Income From Continuing Operations | -12.88 | -51.31 | -64.54 | -28.56 | -47.23 | -47.97 | -59.41 | -74.91 |
| Net Income | -12.88 | -51.31 | -64.54 | -28.56 | -47.23 | -47.97 | -59.41 | -74.91 |
| EPS (Recurring) per share | -0.28 | -1.01 | -1.25 | -0.69 | -0.76 | -0.94 | -1.19 | -1.38 |
| EPS (Basic, Before Extraordinaries) per share | -0.25 | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 |
| EPS (Diluted) per share | -0.25 | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 |
| EBITDA | -10.39 | -48.26 | -60.40 | -33.75 | -30.51 | -42.69 | -53.34 | -59.56 |
| Non-Operating Income (Expense) | 1.69-24.9% | 1.66-26.2% | 1.91-32.5% | 2.04-57.0% | 2.25-22.7% | 2.25-37.0% | 2.83-25.3% | 4.74 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 20.82+14.1% | 21.45+10.3% | 23.44+0.6% | 17.96+3.4% | 18.25+6.7% | 19.44+15.1% | 23.31+46.1% | 17.37+16.3% |
| Price To Sales Ratio ratio | 11.18 | 16.33 | 12.22 | 14.48 | 10.82 | 10.43 | 13.19 | 10.65 |
| Gross Margin % | 91.97 | 92.47 | 91.06 | 92.55 | 91.62 | 89.62 | 90.18 | 89.40 |
| Operating Margin % | -5.18 | -23.42 | -32.83 | -18.38 | -19.25 | -29.87 | -45.67 | -51.89 |
| Net Margin % | -4.96 | -23.50 | -33.76 | -14.57 | -27.62 | -31.97 | -48.91 | -63.08 |
| Shares Outstanding million shares | 52.58+4.5% | 52.30+5.0% | 51.42+4.5% | 50.88+4.5% | 50.31+3.9% | 49.82+4.2% | 49.22+3.7% | 48.67+2.8% |
| Market Capitalization | 7,593.86+25.3% | 12,595.82+145.1% | 8,645.93+52.0% | 9,207.36+124.5% | 6,060.54+40.5% | 5,139.79+34.4% | 5,687.51+50.4% | 4,100.40+8.9% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 322.93+2.4% | 315.35-18.3% | 386.19+92.3% | 200.84+132.3% | 86.47-53.0% | 183.88-16.4% | 219.97+1474.6% | 13.97-58.9% | 34.02 |
| Short Term Receivables | 224.46+58.1% | 142.00+49.8% | 94.82+151.5% | 37.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 27.94+77.6% | 15.73+4.0% | 15.13+250.2% | 4.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 13.65+13.9% | 11.98+47.5% | 8.12+192.1% | 2.78+5460.0% | 0.05-66.7% | 0.15-63.4% | 0.41-67.2% | 1.25-2.3% | 1.28 |
| Total Current Assets | 588.99+21.4% | 485.06-3.8% | 504.26+105.3% | 245.64+183.9% | 86.52-53.0% | 184.02-16.5% | 220.38+1348.0% | 15.22-56.9% | 35.30 |
| Net Property, Plant & Equipment | 23.74+130.7% | 10.29+35.0% | 7.62+568.4% | 1.14+21.3% | 0.94-47.5% | 1.79+5866.7% | 0.03-40.0% | 0.05-28.6% | 0.07 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 52.56-10.8% | 58.94-9.8% | 65.33-6.6% | 69.97 | - | - | - | - | - |
| Other Assets | 24.51+72.5% | 14.21+28.8% | 11.03-25.1% | 14.72+4500.0% | 0.320.0% | 0.32+128.6% | 0.14+27.3% | 0.11-42.1% | 0.19 |
| Total Assets | 689.80+21.3% | 568.50-3.4% | 588.24+77.5% | 331.48+277.6% | 87.79-52.8% | 186.13-15.6% | 220.55+1334.0% | 15.38-56.7% | 35.56 |
| Short Term Debt Incl. Current Port. of LT Debt | 72.98+452.5% | 13.21+940.2% | 1.27+202.4% | 0.42-32.3% | 0.62-49.2% | 1.22-53.1% | 2.60-21.0% | 3.29+0.6% | 3.27 |
| Accounts Payable | 65.54-9.0% | 72.00+77.0% | 40.68+5.4% | 38.61+193.6% | 13.15-2.6% | 13.50+23.4% | 10.94+196.5% | 3.69+7.3% | 3.44 |
| Income Tax Payable | 0.10-89.6% | 0.96 | - | - | - | - | - | - | - |
| Other Current Liabilities | 240.22+66.9% | 143.93+48.5% | 96.91+68.5% | 57.53+518.6% | 9.30+6.8% | 8.71-20.5% | 10.95+185.2% | 3.84-29.8% | 5.47 |
| Total Current Liabilities | 378.84+64.6% | 230.10+65.7% | 138.85+43.8% | 96.56+318.6% | 23.07-1.6% | 23.44-4.3% | 24.49+126.3% | 10.82-11.2% | 12.18 |
| Long Term Debt | 145.13-23.5% | 189.70+2.5% | 185.10+96.4% | 94.26+92.0% | 49.09+0.4% | 48.90+182.2% | 17.33+378.7% | 3.62-45.6% | 6.66 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 77.54-15.4% | 91.68+25.1% | 73.30+135.7% | 31.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 601.51+17.6% | 511.48+28.8% | 397.26+79.0% | 221.92+207.6% | 72.15-0.3% | 72.34+72.9% | 41.83+189.7% | 14.44-23.4% | 18.84 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 88.30+54.9% | 57.02-70.1% | 190.98+74.3% | 109.56+601.0% | 15.63-86.3% | 113.79-36.3% | 178.72+18912.8% | 0.94-94.4% | 16.72 |
| Total Shareholders Equity | 88.30+54.9% | 57.02-70.1% | 190.98+74.3% | 109.56+601.0% | 15.63-86.3% | 113.79-36.3% | 178.72+18912.8% | 0.94-94.4% | 16.72 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 88.30+54.9% | 57.02-70.1% | 190.98+74.3% | 109.56+601.0% | 15.63-86.3% | 113.79-36.3% | 178.72+18912.8% | 0.94-94.4% | 16.72 |
| Total Liabilities & Stockholders Equity | 689.80+21.3% | 568.50-3.4% | 588.24+77.5% | 331.48+277.6% | 87.79-52.8% | 186.13-15.6% | 220.55+1334.0% | 15.38-56.7% | 35.56 |
| Book Value Per Share per share | 1.74+48.7% | 1.17-71.0% | 4.03+59.9% | 2.52+514.6% | 0.41-86.5% | 3.04-37.2% | 4.84+16033.3% | 0.03-95.5% | 0.66 |
| Tangible Book Value Per Share per share | 0.70 | -0.04-101.5% | 2.65+191.2% | 0.91+122.0% | 0.41-86.5% | 3.04-37.2% | 4.84+16033.3% | 0.03-95.5% | 0.66 |
| Full-Time Employees people | 925+35.4% | 683+25.3% | 545+42.3% | 383+254.6% | 108+80.0% | 60+33.3% | 45+55.2% | 29+16.0% | 25 |
| Price to Book Ratio ratio | 71.99 | 44.11 | 13.97 | 21.28 | 91.41 | 26.76 | 21.36 | 90.47 | 7.87 |
| Return on Assets % | -29.11 | -49.66 | -52.02 | -89.27 | -95.21 | -50.60 | -57.94 | -121.59 | -78.47 |
| Return on Equity % | -252.11 | -231.63 | -159.21 | -298.97 | -201.51 | -70.36 | -76.08 | -350.78 | -151.19 |
| Return on Invested Capital % | -78.47 | -116.42 | -63.61 | -91.82 | -201.49 | -63.25 | -34.86 | -679.46 | -123.79 |
| Quick Ratio ratio | 1.48 | 2.04 | 3.52 | 2.50 | 3.75 | 7.85 | 9.00 | 1.41 | 2.90 |
| Current Ratio ratio | 1.55 | 2.11 | 3.63 | 2.54 | 3.75 | 7.85 | 9.00 | 1.41 | 2.90 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -157.29 | -183.17 | -287.22 | -239.24 | -187.13 | -130.40 | -102.90 | -68.35 | -30.97 |
| Depreciation | 10.58 | 9.06+13.8% | 7.96+16.5% | 6.83+22.8% | 5.56+379.3% | 1.16+1350.0% | 0.08+100.0% | 0.04-20.0% | 0.05 |
| Other Funds (Non Cash) | 91.71 | 103.76-11.3% | 116.95+1.1% | 115.72+179.6% | 41.39+103.0% | 20.39-14.9% | 23.95+253.8% | 6.77 | -0.66 |
| Funds from Operations | -54.99 | -70.35 | -162.31 | -116.69 | -140.18 | -108.86 | -78.87 | -61.54 | -31.58 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -26.78 | -23.06-168.0% | 33.90 | -28.39-219.9% | 23.67+7296.9% | 0.32-22.0% | 0.41-97.3% | 15.17+898.0% | 1.52 |
| Cash from Operating Activities | -81.77 | -93.41 | -128.41 | -145.08 | -116.51 | -108.54 | -78.46 | -46.38 | -30.05 |
| Capital Expenditures | -0.84 | -0.48 | -0.27 | -0.58 | -0.70 | -0.31 | -0.05 | -0.02 | -0.03 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | -53.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.84 | -0.48 | -0.27 | -0.58 | -53.70 | -0.31 | -0.05 | -0.02 | -0.03 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 102.44 | 126.27+78.7% | 70.65-72.3% | 255.50+5.1% | 243.04+1993.4% | 11.61-23.5% | 15.18-93.7% | 239.63+1689.6% | 13.39 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 102.44 | 126.27+78.7% | 70.65-72.3% | 255.50+5.1% | 243.04+1993.4% | 11.61-23.5% | 15.18-93.7% | 239.63+1689.6% | 13.39 |
| Proceedsfrom Stock Options | 25.10 | 66.71+66.9% | 39.97-83.6% | 243.08+2.7% | 236.79+3184.2% | 7.21-49.0% | 14.13-94.1% | 238.23+1749.6% | 12.88 |
| Issuance or Reduction of Debt, Net | -3.84 | -7.75 | -0.99-101.2% | 83.56+87.7% | 44.51 | 0.00-100.0% | 28.34+122.1% | 12.76 | -3.33 |
| Change in Long Term Debt | -3.84 | -7.75 | -0.99-101.2% | 83.56+87.7% | 44.51 | 0.00-100.0% | 28.34+122.1% | 12.76 | -3.33 |
| Issuance of Long Term Debt | 280.00 | 326.36 | 0.00-100.0% | 83.56+87.7% | 44.51 | 0.00-100.0% | 50.00+150.0% | 20.00 | 0.00 |
| Reduction of Long Term Debt | -283.84 | -334.11 | -0.99 | 0.00 | 0.00 | 0.00 | -21.66 | -7.24 | -3.33 |
| Net Financing Active Other Cash Flow | -27.40 | -17.05 | -11.82 | -8.05 | -2.97 | -0.18 | -1.10 | 0.00 | -0.03 |
| Other Financing Activities Uses | -27.40 | -17.05 | -11.82 | -8.05 | -2.97 | -0.18 | -1.10 | 0.00 | -0.03 |
| Cash from Financing Activities | 71.20 | 101.47+75.4% | 57.84-82.5% | 331.01+16.3% | 284.58+2387.6% | 11.44-73.0% | 42.41-83.2% | 252.39+2416.4% | 10.03 |
| Net Change in Cash | -11.41 | 7.58 | -70.84-138.2% | 185.35+62.1% | 114.37 | -97.40 | -36.09-117.5% | 206.00 | -20.05 |
| Free Cash Flow | -82.61 | -93.89 | -128.68 | -145.66 | -117.21 | -108.84 | -78.50 | -46.39 | -30.09 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 313.86-3.5% | 319.85+5.6% | 305.11+1.4% | 322.93+2.4% | 325.27-0.6% | 303.02-4.0% | 300.91-9.2% | 315.35-18.3% |
| Short Term Receivables | 343.11+74.6% | 277.46+39.6% | 251.06+55.6% | 224.46+58.1% | 196.51+58.3% | 198.82+65.2% | 161.40+59.1% | 142.00+49.8% |
| Inventories | 42.58+79.1% | 37.88+105.4% | 31.52+93.1% | 27.94+77.6% | 23.77+66.6% | 18.44+21.2% | 16.32+4.7% | 15.73+4.0% |
| Other Current Assets | 25.08+26.7% | 21.38+30.8% | 23.52+46.9% | 13.65+13.9% | 19.79+47.6% | 16.34+38.4% | 16.01+33.1% | 11.98+47.5% |
| Total Current Assets | 724.64+28.2% | 656.57+22.4% | 611.21+23.6% | 588.99+21.4% | 565.34+18.0% | 536.62+15.9% | 494.63+7.4% | 485.06-3.8% |
| Net Property, Plant & Equipment | 31.71+19.0% | 30.46+19.5% | 24.01-4.7% | 23.74+130.7% | 26.65+315.8% | 25.50+275.6% | 25.19+162.1% | 10.29+35.0% |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 47.79-11.8% | 49.40-11.4% | 50.99-11.1% | 52.56-10.8% | 54.17-10.5% | 55.77-10.3% | 57.36-10.0% | 58.94-9.8% |
| Other Assets | 22.64-1.9% | 25.02+14.3% | 27.40+40.6% | 24.51+72.5% | 23.09+50.0% | 21.89+34.7% | 19.49+63.9% | 14.21+28.8% |
| Total Assets | 826.77+23.5% | 761.45+19.0% | 713.61+19.6% | 689.80+21.3% | 669.25+19.2% | 639.78+16.7% | 596.67+9.3% | 568.50-3.4% |
| Short Term Debt Incl. Current Port. of LT Debt | 76.22+4.1% | 76.13-2.9% | 73.82+3152.0% | 72.98+452.5% | 73.23+2416.5% | 78.43+2893.5% | 2.27+27.5% | 13.21+940.2% |
| Accounts Payable | 96.08+77.2% | 78.97-13.8% | 106.70+24.6% | 65.54-9.0% | 54.23-15.6% | 91.63+49.4% | 85.66+59.2% | 72.00+77.0% |
| Income Tax Payable | 0.00 | 0.00 | 0.10-89.6% | 0.10-89.6% | 0.00-100.0% | 0.00-100.0% | 0.96+95.9% | 0.96 |
| Other Current Liabilities | 337.43+44.9% | 305.35+77.5% | 258.59+66.8% | 240.22+66.9% | 232.83+81.1% | 172.04+40.9% | 155.03+76.2% | 143.93+48.5% |
| Total Current Liabilities | 509.72+41.5% | 460.45+34.6% | 439.21+80.1% | 378.84+64.6% | 360.29+83.6% | 342.10+83.4% | 243.91+69.3% | 230.10+65.7% |
| Long Term Debt | 148.01+1.8% | 148.56+2.5% | 146.08-30.1% | 145.13-23.5% | 145.36-23.2% | 144.96-23.4% | 208.96+11.4% | 189.70+2.5% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 63.61-29.2% | 69.14-13.2% | 73.73-18.6% | 77.54-15.4% | 89.87+8.3% | 79.66+14.4% | 90.59+29.4% | 91.68+25.1% |
| Total Liabilities | 721.34+21.1% | 678.14+19.7% | 659.02+21.3% | 601.51+17.6% | 595.52+27.1% | 566.71+27.2% | 543.47+35.3% | 511.48+28.8% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 105.43+43.0% | 83.30+14.0% | 54.59+2.6% | 88.30+54.9% | 73.73-20.6% | 73.08-28.9% | 53.20-63.1% | 57.02-70.1% |
| Total Shareholders Equity | 105.43+43.0% | 83.30+14.0% | 54.59+2.6% | 88.30+54.9% | 73.73-20.6% | 73.08-28.9% | 53.20-63.1% | 57.02-70.1% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 105.43+43.0% | 83.30+14.0% | 54.59+2.6% | 88.30+54.9% | 73.73-20.6% | 73.08-28.9% | 53.20-63.1% | 57.02-70.1% |
| Total Liabilities & Stockholders Equity | 826.77+23.5% | 761.45+19.0% | 713.61+19.6% | 689.80+21.3% | 669.25+19.2% | 639.78+16.7% | 596.67+9.3% | 568.50-3.4% |
| Book Value Per Share per share | 2.01+36.7% | 1.59+8.2% | 1.06-1.9% | 1.74+48.7% | 1.47-23.4% | 1.47-31.6% | 1.08-64.4% | 1.17-71.0% |
| Tangible Book Value Per Share per share | 1.10+182.1% | 0.65+85.7% | 0.07 | 0.70 | 0.39-41.8% | 0.35-58.8% | -0.08-104.7% | -0.04-101.5% |
| Full-Time Employees people | 1,390+70.3% | 1,346 | 1,220 | 925+35.4% | 816 | - | - | 683+25.3% |
| Price to Book Ratio ratio | 71.99 | 230.57 | 97.40 | 124.62 | 82.79 | 96.57 | 99.55 | 44.11 |
| Return on Assets % | -21.03 | -27.35 | -28.74 | -29.11 | -37.30 | -41.57 | -48.72 | -49.66 |
| Return on Equity % | -175.59 | -245.10 | -349.38 | -252.11 | -275.50 | -280.68 | -282.16 | -231.63 |
| Return on Invested Capital % | -5.08 | -22.13 | -32.16 | -12.23 | -21.56 | -22.00 | -22.66 | -30.36 |
| Quick Ratio ratio | 1.34 | 1.34 | 1.32 | 1.48 | 1.50 | 1.51 | 1.96 | 2.04 |
| Current Ratio ratio | 1.42 | 1.43 | 1.39 | 1.55 | 1.57 | 1.57 | 2.03 | 2.11 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -12.88 | -51.31 | -64.54 | -28.56 | -47.23 | -47.97 | -59.41 | -74.91 |
| Depreciation | 3.06+27.0% | 2.89+28.4% | 2.37+11.3% | 2.27+9.7% | 2.41+17.0% | 2.25+13.1% | 2.13+16.4% | 2.07+19.0% |
| Other Funds (Non Cash) | 25.02-32.5% | 26.67-3.5% | 25.03+4.1% | 14.99-55.7% | 37.08-4.6% | 27.64+13.5% | 24.05+21.0% | 33.84-46.4% |
| Funds from Operations | 15.20 | -21.75 | -37.14 | -11.29 | -7.74 | -18.09 | -33.23 | -39.00 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -24.66-380.9% | -11.20 | 16.44 | -7.36-157.5% | 8.78+74.6% | -14.33-162.6% | -10.15 | 12.80+274.3% |
| Cash from Operating Activities | -9.47-1001.9% | -32.95 | -20.70 | -18.65 | 1.05 | -32.42 | -43.38 | -26.20 |
| Capital Expenditures | -0.20 | -0.45 | -0.12 | -0.07 | -0.06 | -0.01 | -0.34 | -0.03 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.20 | -0.45 | -0.12 | -0.07 | -0.06 | -0.01 | -0.34 | -0.03 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 10.06-60.2% | 55.24+26.2% | 16.23-55.3% | 20.91+21.3% | 25.28-23.7% | 43.78+146.2% | 36.29+1351.6% | 17.24+1399.1% |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 10.06-60.2% | 55.24+26.2% | 16.23-55.3% | 20.91+21.3% | 25.28-23.7% | 43.78+146.2% | 36.29+1351.6% | 17.24+1399.1% |
| Proceedsfrom Stock Options | 0.00-100.0% | 13.27-58.7% | 6.25-67.5% | 5.58-48.9% | 9.76-51.3% | 32.12+256.1% | 19.26 | 10.92 |
| Issuance or Reduction of Debt, Net | -1.42 | -1.21 | -0.67 | -0.54 | -0.66 | -6.14 | -0.40 | -0.33-138.8% |
| Change in Long Term Debt | -1.42 | -1.21 | -0.67 | -0.54 | -0.66 | -6.14 | -0.40 | -0.33-138.8% |
| Issuance of Long Term Debt | 70.000.0% | 70.00-62.4% | 70.00 | 70.00 | 70.00 | 186.36 | 0.00 | 0.00-100.0% |
| Reduction of Long Term Debt | -71.42 | -71.21 | -70.67 | -70.54 | -70.66 | -192.51 | -0.40 | -0.33 |
| Net Financing Active Other Cash Flow | -4.96 | -5.88 | -12.56 | -3.99 | -3.35 | -3.09 | -6.62 | -2.66 |
| Other Financing Activities Uses | -4.96 | -5.88 | -12.56 | -3.99 | -3.35 | -3.09 | -6.62 | -2.66 |
| Cash from Financing Activities | 3.67-82.7% | 48.15+39.4% | 2.99-89.8% | 16.39+15.1% | 21.27-30.1% | 34.54+140.2% | 29.27 | 14.24 |
| Net Change in Cash | -5.99-126.9% | 14.74+598.6% | -17.83 | -2.34 | 22.26+90.6% | 2.11 | -14.44 | -11.99 |
| Free Cash Flow | -9.67-1076.8% | -33.40 | -20.82 | -18.72 | 0.99 | -32.44 | -43.71 | -26.23 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Product | 381.68 | 633.80 | +66.1% | 99.3% |
| Royalty and Milestone | 4.02 | 4.70 | +17.0% | 0.7% |
| Total | 385.69 | 638.50 | +65.5% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Non-US | 7.53 | 9.88 | +31.1% | 1.5% |
| United States | 378.16 | 628.62 | +66.2% | 98.5% |
| Total | 385.69 | 638.50 | +65.5% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.35% | 3.3M | 44.4M | 782.89K |
| 2026-10-15 | 7.04% | 3.1M | 44.2M | 725.95K |
| 2026-09-30 | 7.48% | 3.3M | 44.2M | 701.01K |
| 2026-09-15 | 7.11% | 3.1M | 44.2M | 839.36K |
| 2026-08-31 | 6.97% | 3.1M | 44.2M | 849.47K |
| 2026-08-14 | 7.28% | 3.2M | 44.0M | 867.66K |
| 2026-07-31 | 7.90% | 3.4M | 43.1M | 896.22K |
| 2026-07-15 | 7.01% | 3.0M | 43.1M | 927.28K |
| 2026-06-30 | 6.11% | 2.6M | 43.1M | 889.24K |
| 2026-06-15 | 7.63% | 3.3M | 43.0M | 716.77K |
| 2026-05-29 | 7.18% | 3.1M | 43.1M | 696.57K |
| 2026-05-15 | 6.45% | 2.8M | 43.1M | 709.69K |
| 2026-04-30 | 6.36% | 2.7M | 43.2M | 638.71K |
| 2026-04-15 | 6.23% | 2.7M | 43.0M | 610.18K |
| 2026-03-31 | 6.61% | 2.8M | 42.8M | 653.83K |
| 2026-03-13 | 6.46% | 2.8M | 42.8M | 673.98K |
| 2026-02-27 | 6.06% | 2.6M | 42.8M | 657.03K |
| 2026-02-13 | 6.34% | 2.7M | 42.8M | 639.51K |
| 2026-01-30 | 6.54% | 2.7M | 41.5M | 654.60K |
| 2026-01-15 | 6.53% | 2.7M | 41.5M | 616.56K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 110 | 32.80 | 36.80 | 0.00 | 174.2% | 0.00 | 0.00 | 0.898 | -0.401 | 0.038 |
| call | 115 | 28.10 | 31.90 | 20.00 | 155.6% | 7.00 | 0.00 | 0.885 | -0.384 | 0.041 |
| call | 120 | 23.50 | 27.00 | 23.20 | 137.1% | 28.00 | 0.00 | 0.869 | -0.364 | 0.045 |
| call | 125 | 18.50 | 22.00 | 19.50 | 116.6% | 21.00 | 0.00 | 0.849 | -0.340 | 0.050 |
| call | 130 | 14.10 | 17.50 | 18.00 | 104.2% | 24.00 | 2.00 | 0.820 | -0.311 | 0.055 |
| call | 135 | 10.10 | 13.30 | 14.50 | 93.7% | 32.00 | 0.00 | 0.728 | -0.393 | 0.070 |
| call | 140 | 5.90 | 9.50 | 11.46 | 84.7% | 127 | 17.00 | 0.641 | -0.361 | 0.079 |
| call | 145 | 3.50 | 6.80 | 4.75 | 83.5% | 66.00 | 55.00 | 0.512 | -0.444 | 0.084 |
| call | 150 | 1.40 | 4.60 | 3.27 | 81.6% | 214 | 25.00 | 0.392 | -0.405 | 0.081 |
| call | 155 | 0.20 | 2.80 | 2.80 | 77.8% | 141 | 0.00 | 0.287 | -0.359 | 0.072 |
| call | 160 | 0.55 | 2.05 | 1.20 | 82.6% | 375 | 6.00 | 0.217 | -0.331 | 0.062 |
| call | 165 | 0.30 | 0.85 | 0.50 | 73.0% | 1,151 | 451 | 0.118 | -0.196 | 0.042 |
| call | 170 | 0.00 | 0.50 | 1.40 | 74.0% | 53.00 | 0.00 | 0.074 | -0.142 | 0.030 |
| call | 175 | 0.05 | 2.30 | 0.35 | 83.9% | 593 | 0.00 | 0.067 | -0.148 | 0.028 |
| call | 180 | 0.05 | 2.20 | 0.16 | 93.2% | 170 | 0.00 | 0.062 | -0.154 | 0.026 |
| call | 185 | 0.00 | 0.10 | 0.10 | 77.9% | 340 | 877 | 0.017 | -0.046 | 0.009 |
| call | 190 | 0.05 | 0.30 | 0.08 | 84.9% | 300 | 32.00 | 0.016 | -0.047 | 0.009 |
| call | 195 | 0.00 | 0.85 | 0.05 | 91.6% | 510 | 6.00 | 0.015 | -0.048 | 0.008 |
| call | 200 | 0.00 | 2.15 | 1.50 | 98.1% | 22.00 | 0.00 | 0.014 | -0.048 | 0.008 |
| call | 210 | 0.00 | 2.15 | 0.10 | 110.5% | 26.00 | 0.00 | 0.013 | -0.050 | 0.007 |
| call | 220 | 0.00 | 2.15 | 0.20 | 122.1% | 145 | 0.00 | 0.012 | -0.051 | 0.007 |
| call | 230 | 0.00 | 2.15 | 0.20 | 178.8% | 33.00 | 0.00 | 0.064 | -0.309 | 0.028 |
| call | 240 | 0.00 | 2.15 | 0.20 | 191.8% | 23.00 | 0.00 | 0.061 | -0.318 | 0.027 |
| call | 250 | 0.00 | 2.15 | 0.15 | 204.1% | 21.00 | 0.00 | 0.058 | -0.326 | 0.026 |
| call | 260 | 0.00 | 2.15 | 0.20 | 215.7% | 19.00 | 0.00 | 0.056 | -0.333 | 0.025 |
| call | 270 | 0.00 | 2.15 | 0.00 | 171.0% | 0.00 | 0.00 | 0.009 | -0.056 | 0.005 |
| call | 280 | 0.00 | 2.15 | 0.81 | 179.4% | 7.00 | 0.00 | 0.009 | -0.056 | 0.005 |
| call | 290 | 0.00 | 2.15 | 0.00 | 187.5% | 0.00 | 0.00 | 0.008 | -0.057 | 0.005 |
| call | 300 | 0.00 | 2.15 | 0.00 | 195.2% | 0.00 | 0.00 | 0.008 | -0.058 | 0.005 |
| call | 310 | 0.00 | 2.15 | 0.00 | 202.6% | 0.00 | 0.00 | 0.008 | -0.058 | 0.004 |
| call | 320 | 0.00 | 2.15 | 0.00 | 209.8% | 0.00 | 0.00 | 0.007 | -0.059 | 0.004 |
| put | 110 | 0.00 | 2.25 | 0.00 | 162.0% | 0.00 | 0.00 | -0.102 | -0.388 | 0.038 |
| put | 115 | 0.05 | 2.20 | 0.20 | 142.2% | 70.00 | 0.00 | -0.115 | -0.371 | 0.041 |
| put | 120 | 0.00 | 2.30 | 1.38 | 122.9% | 270 | 0.00 | -0.131 | -0.350 | 0.045 |
| put | 125 | 0.00 | 2.40 | 1.58 | 103.7% | 70.00 | 0.00 | -0.151 | -0.326 | 0.050 |
| put | 130 | 0.25 | 1.85 | 1.80 | 84.5% | 70.00 | 3.00 | -0.180 | -0.296 | 0.055 |
| put | 135 | 0.30 | 3.10 | 1.89 | 83.7% | 160 | 3.00 | -0.272 | -0.378 | 0.070 |
| put | 140 | 1.30 | 3.20 | 2.32 | 61.9% | 72.00 | 6.00 | -0.359 | -0.346 | 0.079 |
| put | 145 | 3.50 | 6.90 | 4.75 | 78.7% | 37.00 | 1.00 | -0.488 | -0.428 | 0.084 |
| put | 150 | 6.70 | 8.90 | 10.20 | 66.7% | 21.00 | 0.00 | -0.608 | -0.388 | 0.081 |
| put | 155 | 10.10 | 13.00 | 9.25 | 73.7% | 18.00 | 0.00 | -0.713 | -0.342 | 0.072 |
| put | 160 | 14.40 | 17.50 | 27.13 | 82.0% | 7.00 | 0.00 | -0.783 | -0.313 | 0.062 |
| put | 165 | 18.90 | 22.50 | 18.30 | 96.1% | 24.00 | 2.00 | -0.882 | -0.178 | 0.042 |
| put | 170 | 23.70 | 27.30 | 37.47 | 105.4% | 61.00 | 0.00 | -0.926 | -0.123 | 0.030 |
| put | 175 | 28.60 | 32.10 | 41.85 | 113.3% | 3.00 | 0.00 | -0.933 | -0.129 | 0.028 |
| put | 180 | 33.60 | 37.10 | 43.02 | 124.5% | 0.00 | 0.00 | -0.938 | -0.134 | 0.026 |
| put | 185 | 38.50 | 42.10 | 29.50 | 135.0% | 0.00 | 0.00 | -0.983 | -0.025 | 0.009 |
| put | 190 | 43.50 | 47.10 | 24.52 | 145.1% | 0.00 | 0.00 | -0.984 | -0.025 | 0.009 |
| put | 195 | 48.50 | 52.10 | 0.00 | 154.7% | 0.00 | 0.00 | -0.985 | -0.026 | 0.008 |
| put | 200 | 53.50 | 57.10 | 59.00 | 163.9% | 10.00 | 0.00 | -0.986 | -0.026 | 0.008 |
| put | 210 | 63.50 | 67.60 | 66.74 | 193.8% | 0.00 | 0.00 | -0.987 | -0.027 | 0.007 |
| put | 220 | 73.60 | 77.10 | 76.76 | 197.3% | 0.00 | 0.00 | -0.988 | -0.027 | 0.007 |
| put | 230 | 83.60 | 87.10 | 61.19 | 212.4% | 0.00 | 0.00 | -0.989 | -0.027 | 0.006 |
| put | 240 | 93.60 | 97.10 | 0.00 | 226.6% | 0.00 | 0.00 | -0.990 | -0.027 | 0.006 |
| put | 250 | 103.5 | 107.1 | 0.00 | 240.0% | 0.00 | 0.00 | -0.990 | -0.026 | 0.006 |
| put | 260 | 113.6 | 117.1 | 0.00 | 252.7% | 0.00 | 0.00 | -0.991 | -0.026 | 0.005 |
| put | 270 | 123.6 | 127.1 | 0.00 | 264.7% | 0.00 | 0.00 | -0.991 | -0.026 | 0.005 |
| put | 280 | 133.6 | 137.1 | 0.00 | 276.2% | 0.00 | 0.00 | -0.991 | -0.025 | 0.005 |
| put | 290 | 143.6 | 147.1 | 161.4 | 287.2% | 0.00 | 0.00 | -0.992 | -0.025 | 0.005 |
| put | 300 | 153.6 | 157.1 | 0.00 | 297.7% | 0.00 | 0.00 | -0.992 | -0.024 | 0.005 |
| put | 310 | 163.6 | 167.1 | 0.00 | 307.8% | 0.00 | 0.00 | -0.992 | -0.024 | 0.004 |
| put | 320 | 173.5 | 177.1 | 0.00 | 317.4% | 0.00 | 0.00 | -0.993 | -0.023 | 0.004 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-02 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-02 | 8-K | Current report | 2026-11-02 | SEC |
| 2026-09-03 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-08-10 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-10 | 8-K | Current report | 2026-08-10 | SEC |
| 2026-08-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-05 | SEC |
| 2026-08-06 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-07-27 | SCHEDULE 13G/A | SEC | ||
| 2026-07-15 | 8-K | Current report | 2026-07-15 | SEC |
| 2026-07-01 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-07-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-01 | SEC |
| 2026-06-11 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-11 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-09 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-09 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-09 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-09 | 8-K | Current report | 2026-06-05 | SEC |
| 2026-06-09 | 8-K | Current report | 2026-06-05 | SEC |
| 2026-06-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-09 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 2.09M | 1 |
| 2026-08 | 0 | 0 | 10.54M | 2 |
| 2026-07 | 0 | 0 | 11.93M | 1 |
| 2026-06 | 0 | 0 | 22.96M | 9 |
| 2026-05 | 0 | 0 | 2.48M | 3 |
| 2026-04 | 0 | 0 | 1.37M | 1 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 15.77M | 3 |
| 2026-01 | 0 | 0 | 27.52M | 5 |
| 2025-12 | 0 | 0 | 17.86M | 4 |
| 2025-11 | 0 | 0 | 21.82M | 3 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 6.03% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.85% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.82% |
| Invesco Ltd. | 3.69% |
| FMR LLC | 2.76% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.93% |
| UBS Group AG | 1.62% |
| STATE STREET CORP | 1.57% |
| MORGAN STANLEY | 1.56% |
| FRANKLIN TEMPLETON INC | 1.42% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.70% |
| VANGUARD SMALL-CAP INDEX FUND | 1.95% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.12% |
| VANGUARD EXPLORER FUND | 1.03% |
| Invesco Discovery Fund | 1.02% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.96% |
| First Trust NYSE Arca Biotechnology Index Fund | 0.83% |
| Fidelity Small Cap Index Fund | 0.80% |
| iShares Biotechnology ETF | 0.59% |
| Franklin Dynatech Fund | 0.58% |
OakChart. AXSM. Cached 15 minutes. Terms